Optimising cardiovascular care of patients with multiple myeloma

Cardiovascular events affect up to 7.5% of individuals with multiple myeloma (MM), due to a combination of patient, disease and treatment-related factors. This review discusses these factors in detail and recommendations on the optimum cardiovascular care of patients with MM.

Heart